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The significance of cytokine production by CD4
 
 
 
 regulatory T (T reg) cells after antigen 
exposure in vivo and its impact on their regulatory activity remains unclear. Pretreatment 
with donor alloantigen under the cover of anti-CD4 therapy generates alloantigen reactive 
T reg cells that can prevent rejection of donor-specific skin grafts that are mediated by 
naive CD45RB
 
high
 
CD4
 
 
 
 T cells. To examine the kinetics and importance of cytokine gene 
transcription by such alloantigen-reactive T reg cells, pretreated mice were rechallenged 
with donor alloantigen in vivo. CD25
 
 
 
CD4
 
 
 
 T cells, but not CD25
 
 
 
CD4
 
 
 
 T cells, showed a 
fivefold increase in IFN-
 
 
 
 mRNA expression within 24 h of reencountering alloantigen in 
vivo. This expression kinetic was highly antigen-specific and was of functional significance. 
Neutralizing IFN-
 
 
 
 at the time of cotransfer of alloantigen reactive T reg cells, together 
with CD45RB
 
high
 
CD4
 
 
 
 effector T cells into 
 
Rag
 
   
 
 skin graft recipients, resulted in skin graft 
necrosis in all recipients; the generation and function of alloantigen-reactive T reg cells was 
impaired dramatically in IFN-
 
 
 
–deficient mice. These data support a unique role for IFN-
 
 
 
 
in the functional activity of alloantigen-reactive T reg cells during the development of 
operational tolerance to donor alloantigens in vivo.
 
T cell subpopulations with regulatory function
(regulatory T [T reg] cells) can be identified
and were shown to play a key role in controlling
immune responsiveness in vivo; however, their
precise mechanism of action remains contro-
versial. In particular, how cytokines contribute
to immunoregulation by T reg cells, if at all, is
far from clear. In vivo, TGF-
 
 
 
 and IL-10 play
a role in immunoregulation in some (1–4), but
not all, settings (5). In vitro, antigen stimulation
of T reg cells often results in much higher levels
of expression of TGF-
 
 
 
 and IL-10 than those
produced by naive or effector T cells (6–8).
However, the significance of this increased
TGF-
 
 
 
 and IL-10 expression in vitro is not
understood because several groups have shown
that neutralization of TGF-
 
 
 
 and IL-10 has
no effect on immunoregulatory activity (5–7).
Moreover, in vitro stimulation of T reg cells
produces little or no IL-2 and IFN-
 
 
 
 compared
with that produced by effector cells under similar
conditions; however, IL-2 and IFN-
 
 
 
 are re-
quired for the induction of tolerance to alloan-
tigens in vivo (9, 10). Thus, the kinetics and
functional significance of cytokine expression
by T reg cells after in vivo antigen stimulation
require clarification.
T reg cells can play a major role during the
induction and maintenance of operational toler-
ance to donor alloantigens in vivo (11). We
showed previously that pretreatment with do-
nor-specific transfusion in combination with
anti-CD4 therapy generated donor-specific CD4
 
 
 
T reg cells that can suppress rejection of skin
grafts mediated by naive CD45RB
 
high
 
CD4
 
 
 
 T
cells (3). In this model, T reg cells are con-
tained predominantly in the CD25
 
 
 
 fraction,
because equivalent numbers of CD25
 
 
 
CD4
 
 
 
T cells were unable to prevent rejection.
The goal of our present study was to follow
cytokine expression by alloantigen-reactive T
reg cells after in vivo alloantigen stimulation
and to evaluate its functional significance. Here
we demonstrate that in contrast to findings after
ex vivo or in vitro stimulation, CD25
 
 
 
CD4
 
 
 
T cells transiently up-regulate IFN-
 
 
 
 mRNA
expression after alloantigen exposure in vivo.
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This increase in IFN-
 
 
 
 transcription is antigen specific and is
not a result of contamination with antigen-experienced or re-
cently activated T cells. Furthermore, neutralization experi-
ments and studies with IFN-
 
 
 
–deficient mice reveal an im-
portant role of IFN-
 
 
 
 production for the generation and the
function of alloantigen reactive T reg cells in vivo.
 
RESULTS
Cytokine expression of alloantigen reactive regulatory 
T cells after antigen exposure in vivo
 
The first goal of this study was to determine the kinetics of
cytokine mRNA expression by alloantigen-reactive T reg
cells after alloantigen exposure in vivo. Naive CBA (H2
 
k
 
)
mice were pretreated with YTS177 anti-CD4 antibody at
days 
 
 
 
28/27 (200 
 
 
 
g i.v.) and a B10 (H2
 
b
 
) blood transfu-
sion at day 
 
 
 
27 (250 
 
 
 
l whole blood i.v.; 177/B10DST).
This pretreatment protocol results in long-term survival and
induction of operational tolerance to blood donor–spe-
cific—B10—but not third-party allografts transplanted on
day 0 (12). The induction and maintenance of operational
tolerance to donor alloantigens is a result of the development
of alloantigen-reactive immunoregulatory CD4
 
 
 
 T cells
(3). In this study, 177/B10DST-pretreated mice received
an additional B10 blood transfusion 1 d or 3 d before
CD25
 
 
 
CD4
 
 
 
 and CD25
 
 
 
CD4
 
 
 
 T cells were purified from
the spleen by flow cytometry (day 0). B10 blood transfusion
was chosen to provide the antigen challenge instead of a
transplant to ensure that antigen-specific CD25
 
 
 
CD4
 
 
 
 T
cells were found in the spleen and regional lymph nodes
rather than at the graft site, as may be the case after trans-
plantation (13). The presence of CD25
 
 
 
CD4
 
 
 
 T cells with
regulatory potential in the spleen 24 h after an additional
B10 blood transfusion was demonstrated by their ability to
prevent skin graft rejection upon adoptive transfer (Fig. 1).
mRNA expression for the following genes, IL-2, IFN-
 
 
 
,
IL-10, TGF-
 
 
 
, and CTLA-4, was quantified in the sorted T
cell populations. 177/B10DST pretreatment without re-
stimulation by an additional B10 transfusion did not in-
fluence cytokine mRNA expression by CD25
 
 
 
CD4
 
 
 
 or
CD25
 
 
 
CD4
 
 
 
 T cells; cytokine expression levels were the
same as those in T cells that were purified from the spleen of
naive CBA mice (Fig. 2). In contrast, additional exposure
to B10 alloantigens resulted in a fivefold increase in IFN-
 
 
 
mRNA expression by CD25
 
 
 
CD4
 
 
 
 T cells, but not CD25
 
 
 
CD4
 
 
 
 T cells, 24 h after restimulation (P
 
 
 
 
 
 0.001). By 72 h
after alloantigen challenge, IFN-
 
 
 
 mRNA levels in CD25
 
 
 
CD4
 
 
 
 T cells that were purified from pretreated mice had
decreased to less than those in CD25
 
 
 
CD4
 
 
 
 T cells from
naive CBA mice. IL-2 mRNA expression similarly was up-
regulated transiently; however, in this case, the increase was
detected in CD25
 
 
 
CD4
 
 
 
 and CD25
 
 
 
CD4
 
 
 
 T cells (Fig. 2).
In agreement with findings of other groups, CD25
 
 
 
CD4
 
 
 
T cells displayed a higher basal level expression of IL-10
mRNA and they did up-regulate IL-10 mRNA expression
after alloantigen exposure in vivo (Fig. 2). Although
CD25
 
 
 
CD4
 
 
 
 T cells displayed a 50-fold greater basal tran-
scription level of CTLA4 compared with CD25
 
 
 
CD4
 
 
 
 T
cells, they did not up-regulate CTLA4 mRNA expression
after alloantigen exposure in vivo. TGF-
 
 
 
 mRNA expres-
sion in CD25
 
 
 
CD4
 
 
 
 T cells was not greater than that in
CD25
 
 
 
CD4
 
 
 
 T cells; there was no significant increase in
TGF-
 
 
 
 transcription detectable in CD25
 
 
 
CD4
 
 
 
 T cells
from pretreated CBA mice on days 1 or 3 after a B10 blood
challenge.
 
Enhanced IFN-
 
 
 
 expression by alloantigen-reactive 
regulatory T cells is antigen specific
 
Next, we investigated whether the increase in IFN-
 
 
 
mRNA expression by CD25
 
 
 
CD4
 
 
 
 T cells was antigen
specific. Naive CBA mice were pretreated with YTS177
and a BALB/c (H2
 
d
 
) blood transfusion under the same con-
ditions as above. Subsequently, pretreated mice received a
B10 blood transfusion, and cytokine mRNA expression in
CD25
 
 
 
CD4
 
 
 
 and CD25
 
 
 
CD4
 
 
 
 T cells was analyzed 24 h
and 72 h later. As shown in Fig. 3, stimulation of CD25
 
 
 
CD4
 
 
 
 T cells with a third-party antigen did not initiate up-
regulation in IFN-
 
 
 
 mRNA.
 
IFN-
 
 
 
 mRNA up-regulation is not due to contamination 
with recently activated or antigen-experienced T cells
 
To exclude the possibility that the enhanced IFN-
 
 
 
 transcrip-
tion that was observed in CD25
 
 
 
CD4
 
 
 
 T cells was due to the
presence of recently activated T cells, we quantified cytokine
Figure 1. Regulation of skin graft rejection by CD25 CD4  T cells 
from 177/B10DST-pretreated CBA mice after a rechallenge with B10 
blood at day  1. 177/B10DST-pretreated CBA mice were rechallenged 
with 250  l B10 blood on day  1. On day 0, spleens were harvested and 
cells were sorted into CD25 CD4  T cells. CBARag( / ) mice that were re-
constituted with 105 CD45RBhighCD4  T cells from naive CBA mice acutely 
rejected B10 skin grafts (n   6, mean survival time [MST]   17 d). Cotrans-
fer of 1   105 or 2   105 CD25 CD4  T cells from 177/B10DST-pretreated 
CBA mice that were re-exposed to donor alloantigen 1 d before cell purifi-
cation prevented rejection of B10 skin grafts (n   4, MST  100 d).JEM VOL. 201, June 20, 2005 1927
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mRNA expression after a single B10 blood transfusion. As
shown in Fig. 4, a single blood transfusion (days  3 or  1)
without re-exposure to the same alloantigen did not elicit an
increase in cytokine mRNA expression in CD25 CD4  or
CD25 CD4  T cells. To determine if both components
of the pretreatment (i.e., anti-CD4 and blood transfusion)
were necessary to elicit IFN-  mRNA up-regulation in
CD25 CD4  T cells after antigen-specific restimulation in
vivo, CBA mice were pretreated with a B10 blood transfusion
(day  27) only; cytokine transcription by CD25 CD4  and
CD25 CD4  T cells was analyzed after an additional B10
blood transfusion (day  3 or day  1). Although repeated ex-
posure to alloantigen led to the development of antigen-expe-
rienced CD25 CD4  T cells as demonstrated by enhanced
IL-2 transcription within this cell fraction, no increase in
IFN-  mRNA expression in CD25 CD4  T cells was de-
tectable (Fig. 4). These findings support our previous results
where both components—anti-CD4 and donor alloantigen—
were needed for the generation of alloantigen-reactive T reg
cells and prolonged graft survival (3).
In vivo neutralization of IFN-  dramatically reduces 
regulation by CD25 CD4  T cells
Next we investigated whether neutralizing IFN-  at the time
of cell transfer affected the regulatory capacity of CD25 CD4 
T cells. 5   105 CD25 CD4  T cells from 177/B10DST-
pretreated CBA mice were transferred adoptively into
CBA(Rag / ) mice together with 105 CD45RBhighCD4  T
cells from naive CBA mice. At the time of adoptive transfer, a
single dose of 200  g neutralizing anti–mouse IFN-  or iso-
type control antibody was administered i.v.; the following day,
mice received a B10 skin allograft. Administration of anti-IFN- 
mAb abrogated immunoregulation by CD25 CD4  T cells
from pretreated mice (Table I; Fig. 5). Skin grafts in all mice
treated with anti–IFN-  mAb showed severe signs of necrosis
between day 7 and day 11 after transplantation. Four out of
seven mice rejected their grafts completely, whereas in the
other three mice the signs of graft necrosis resolved (P  
0.0338). Because the definition of skin graft rejection that is
used in this study is complete necrosis of the graft, these latter
skin grafts—although damaged—could not be considered as
Figure 2. Cytokine mRNA expression by CD25 CD4  and CD25 CD4  
T cells from 177/B10DST-pretreated CBA mice after additional 
exposure to B10 blood at day  1 or  3 before cell isolation. 177/
B10DST-pretreated CBA mice were rechallenged with 250  l B10 blood on 
days  3 or  1. On day 0, spleens were harvested and cells were sorted 
into CD25 CD4  or CD25 CD4  T cells, and cytokine expression was ana-
lyzed. Data are presented as mean   SD of four independent experiments. 
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rejected. In contrast, all CBA(Rag / ) recipients that received
an isotype control accepted their grafts without any evidence
of tissue necrosis at any time point (Table I). Thus, early pro-
duction of IFN-  in vivo is required for CD25 CD4  T cells
to prevent effector cells from damaging the graft.
Loss of in vivo regulation after IFN-  neutralization is 
accompanied by reduced iNOS transcription within the graft
Transcription of inducible nitric oxide synthase (iNOS) is in-
duced when cells are stimulated with IFN-  (14). To confirm
that treatment with anti–IFN-  mAb resulted in neutralization
of IFN-  in vivo, we analyzed IFN-  and iNOS mRNA ex-
pression in native B10 skin and in B10 skin grafts 7 or 11 d after
transplantation onto unreconstituted or reconstituted Rag( / )
recipients that were treated with an isotype control or anti–
IFN-  mAb (Fig. 6). In the anti–IFN-  mAb–treated group,
only skin grafts from recipients that already had rejected their
grafts completely were included in the day 11 analysis. Skin
grafts that had not been rejected until day 11 were not tested.
Unreconstituted and reconstituted mice displayed elevated
IFN-  mRNA expression in their skin grafts at day 7 after
transplantation. However, reconstituted mice showed an ad-
ditional 50-fold increase in IFN-  transcription at day 11 that
was not detectable in grafts from unreconstituted mice. Thus,
the major increase in IFN-  mRNA expression is dependent
on the presence of T cells. A similar increase in IFN-  tran-
scription was detected in skin grafts from mice that were re-
constituted with CD25 CD4  T cells from 177/B10DST-
pretreated CBA mice (unpublished data). Neutralization of
IFN-  did not affect IFN-  mRNA expression as expected,
but iNOS mRNA levels were reduced dramatically in the
grafts of mice that were treated with the neutralizing IFN- 
mAb compared with those in skin grafts from isotype mAb–
treated mice (Fig. 6). This confirmed the impact of neutraliz-
ing the functional activity of IFN-  in vivo.
Impaired development of alloantigen reactive regulatory 
T cells in the absence of IFN- 
To confirm our hypothesis that IFN-  production by alloanti-
gen-reactive T reg cells is important for their regulatory ca-
pacity in vivo, we tested whether in IFN- –deficient mice the
Figure 3. Up-regulation of IFN-  mRNA expression by 
CD25 CD4  T cells after in vivo stimulation is alloantigen specific. 
CBA mice were pretreated with 200  g YTS177 on days  28 and  27. On 
day  27 they also received 250  l of whole BALB/c blood. Mice were 
rechallenged with 250  l B10 blood on days  3 or  1. On day 0, spleens 
were harvested and cells were sorted into CD25 CD4  or CD25 CD4  
T cells and cytokine mRNA expression was analyzed. Data are presented as 
mean   SD of three independent experiments.
Table I. Neutralization of IFN-  dramatically reduced regulation by CD25 CD4  T cells in vivo
Adoptive transfer
CD45RBhigh CD25  Anti–IFN-  mAb Isotype
Evidence of necrosis
between days 7 and 11
( 50% of graft) Graft survival time Graft survival at 100 d
d
       8/8 9, 10, 11, 13, 4   17 0/8
       4/4 4   9 0/4
       0/6 6   100 6/6
       7/7 10, 2   11, 30, 3   100 3/7a
aP   0.01.JEM VOL. 201, June 20, 2005 1929
ARTICLE
177/DST protocol resulted in the generation of alloantigen-
reactive T reg cells. Because IFN-  gene targeted mice are
not available on the CBA background, we first confirmed that
pretreatment of naive C57BL/6 wild-type mice with 177/
BALBDST resulted in the generation of CD25 CD4  T cells
with the ability to control the rejection of BALB skin grafts
(unpublished data). C57BL/6 wild-type and C57BL/6IFN-
 ( / ) mice were pretreated with 200  g YTS177 on days
 28 and  27. On day  27 they also received 250  l of
whole BALB/c blood. On day 0, spleens were harvested and
CD25 CD4  T cells were purified by cell sorting.
C57BL/6Rag( / ) mice reconstituted with 105 CD45RBhigh
CD4  T cells from naive C57BL/6 mice acutely rejected
BALB/c skin grafts (medium survival time 19 d; range 17–22 d;
Table II; Fig. 5). Cotransfer of 5   105 CD25 CD4  T cells
from 177/BALB/cDST-pretreated C57BL/6 wild-type mice
prevented rejection of BALB/c skin grafts in six out of nine re-
cipients. All mice that were reconstituted with naive 105
CD45RBhighCD4  T cells and 5   105 CD25 CD4  T cells
from 177BALB/cDST-pretreated C57BL/6 IFN- ( / ) mice
showed severe signs of necrosis between day 7 and day 11 after
skin transplantation, and seven out of nine mice completely re-
jected their BALB/c skin grafts (P   0.0138; Table II). These
results further indicate that intact IFN-  production is impor-
tant for the development of the regulatory capacity of alloanti-
gen-reactive T reg cells in vivo.
IFN-  mRNA expression and protein production by 
alloantigen-reactive regulatory T cells after 
in vitro stimulation
Next, we investigated whether stimulation of CD25 CD4 
T cells from pretreated mice with their cognate antigen in
Figure 4. Enhanced IFN-  mRNA expression by alloantigen-reactive 
regulatory T cells after in vivo stimulation is not due to inclusion of 
recently activated T cells or antigen-experienced T cells. (A) Cytokine 
mRNA expression of CD25 CD4  and CD25 CD4  T cells after administration 
of B10 blood on day  3 or  1 to naive CBA mice. On day 0, spleens were 
harvested and cells were sorted into CD25 CD4  or CD25 CD4  T cells and 
cytokine mRNA expression was analyzed. pret, pretreatment. (B) Cytokine 
mRNA expression by CD25 CD4  and CD25 CD4  T cells after administration 
of B10 blood on days  3 or  1 to CBA mice that were pretreated with B10 
blood. CBA mice were pretreated with 250  l of whole B10 blood on day  27. 
Mice were rechallenged with 250  l B10 blood on days  3 or  1. On day 0, 
spleens were harvested and cells were sorted into CD25 CD4  or CD25 CD4  
T cells and cytokine mRNA expression analyzed. Data are presented as mean   
SD of three independent experiments.INTERFERON-  PRODUCTION BY REGULATORY T CELLS | Sawitzki et al. 1930
vivo or in vitro results in increased IFN-  transcription and
IFN-  protein production. CD25 CD4  and CD25 CD4 
T cells from 177/B10DST-pretreated and naive CBA mice
were purified from the spleen by flow cytometry. 2   105
purified T cells were stimulated with 5   105 B10 spleno-
cytes in vitro. At different time points, cells and supernatants
were harvested from the cultures for analysis of IFN-  tran-
scription and protein production by real time RT-PCR and
ELISA, respectively.
As shown in Fig. 7, CD25 CD4  T cells from
YTS177/B10DST-pretreated CBA mice responded to re-
stimulation by B10 APCs in vitro by rapidly increasing
IFN-  transcription. In contrast, CD25 CD4  T cells from
YTS177/B10DST-pretreated mice showed a much slower
response with an increase in IFN-  mRNA expression de-
tectable only 48 h after stimulation. Both cell types from
YTS177/B10DST-pretreated mice responded faster than
their counterparts from naive mice. Thus, similar to the
findings in vivo, CD25 CD4  T cells from YTS177/
B10DST–pretreated mice respond to alloantigen-specific
restimulation by rapidly increasing IFN-  transcription.
Furthermore IFN-  protein also was detectable in the su-
Figure 6. IFN-  neutralization is accompanied by reduced iNOS 
transcription within the graft. IFN-  and iNOS mRNA expression of 
native B10 skins, B10 skins harvested 7 and 11 d after transplantation (Tx) 
onto unreconstituted CBARag( / ) mice and reconstituted CBARag( / ) 
mice with 105 naive CD45RBhighCD4  T cells and 5   105 CD25 CD4  
T cells from 177/B10DST-pretreated CBA mice treated with a single dose 
of 200  g of the neutralizing anti–IFN-  antibody (AN18.17.24) or an iso-
type control antibody (GL113) at the time of cell cotransfer. Grafts were 
harvested, and total RNA was isolated and reverse transcribed. Cytokine 
mRNA expression was analyzed by applying real time RT-PCR. HPRT was 
used as a housekeeping gene and mRNA concentrations were compared 
with the sample content of HPRT. Data are presented as mean   SD of 
three independent experiments.
Figure 5. Loss of in vivo regulation after IFN-  neutralization or 
when cotransferring CD25 CD4  from YTS177/B10DST-pretreated 
IFN- –deficient mice. (A) Neutralization of IFN-  dramatically reduced 
regulation by CD25 CD4  T cells in vivo. CBARag( / ) reconstituted with 
105 CD45RBhighCD4  T cells alone treated with a single dose (200  g) of 
neutralizing anti–IFN-  antibody or an isotype control antibody at the time 
of adoptive cell transfer acutely rejected their B10 skin grafts. Four out of 
seven mice that were reconstituted with naive 105 CD45RBhighCD4  T cells 
and 5   105 CD25 CD4  T cells from 177/B10DST-pretreated CBA mice and 
treated with 200  g of the neutralizing anti–IFN-  antibody at the time of 
cell cotransfer rejected their B10 skin grafts, whereas all recipients that were 
treated with 200  g of an isotype control antibody accepted their grafts. 
(B) Impaired development of alloantigen-reactive T reg cells in the absence 
of IFN- . C57BL/6 wild-type and C57BL/6IFN- ( / ) mice were pretreated 
with 200  g YTS177 on days  28 and  27. On day  27 they also received 
250  l of whole BALB/c blood. On day 0, spleens were harvested and cells 
were sorted into CD25 CD4  T cells. C57BL/6Rag( / ) mice that were recon-
stituted with 105 CD45RBhighCD4  T cells from naive C57BL/6 mice acutely 
rejected BALB/c skin grafts. Cotransfer of 5 x105 CD25 CD4  T cells from 
177/BALB/cDST-pretreated C57BL/6 wild-type mice prevented rejection of 
BALB/c skin grafts in six out of nine recipients. Seven out of nine mice that 
were reconstituted with naive 105 CD45RBhighCD4  T cells and 5   105 
CD25 CD4  T cells from 177/BALB/cDST-pretreated C57BL/6 IFN- ( / ) 
mice at the time of cell cotransfer rejected their BALBc skin grafts.JEM VOL. 201, June 20, 2005 1931
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pernatant of cultures containing CD25 CD4  T cells from
YTS177/B10DST-pretreated mice as early as 12 h after
stimulation, whereas in supernatants from CD25 CD4  T
cells, IFN-  was detectable only after 48 h. These findings
confirm that increased IFN-  mRNA production by CD25 
CD4  T cells from alloantigen-pretreated mice when they
reencounter donor alloantigen translates to increased levels
of IFN-  protein.
CD25 CD4  T cells from YTS177/DST-pretreated mice 
can inhibit cytokine expression by CD45RBhighCD4  
T cells in vitro
To investigate the importance of IFN-  production by
CD25 CD4  T cells for their regulatory potential in more
detail, we also performed suppression assays in vitro.
CD45RBhighCD4  T cells from naive CBA mice were cul-
tured alone or cocultured with CD25 CD4  T cells from
YTS177/B10DST-pretreated CBA mice in the presence of
neutralizing anti–IFN-  antibody or an isotype control. 5  
105 B10 splenocytes were added to the cultures as APCs. Af-
ter 96 h, cells and supernatants were harvested for real time
RT-PCR and ELISA analysis of IL-2 and IFN-  transcrip-
tion and protein production, respectively. The results are
shown in Fig. 8. Stimulation of CD45RBhighCD4  T cells
with allogeneic APCs resulted in an increase in mRNA ex-
pression and protein production of IL-2 and IFN- . When
cocultured with CD25 CD4  T cells from YTS177/
B10DST-pretreated CBA mice, IL-2 and IFN-  expression
was reduced dramatically. Thus, CD25 CD4  T cells from
alloantigen-pretreated mice also are able to inhibit T cell acti-
vation in vitro. Addition of a neutralizing anti–IFN-  anti-
body completely restored IL-2 and IFN-  production in the
coculture, and thus, undermined the importance of IFN- 
for the regulatory capacity of CD25 CD4  T cells from
YTS177/DST-pretreated CBA mice.
DISCUSSION
The data presented here demonstrate that restimulation of
alloantigen-reactive T reg cells by alloantigen in vivo results
in a rapid and transient increase in IFN-  mRNA expression
(Fig. 2). This increase in IFN-  transcription is antigen spe-
cific and is not due to contamination with recently activated
or antigen-experienced T cells (Figs. 3 and 4). Furthermore,
immunoregulation by CD25 CD4  T cells in vivo is de-
pendent on this early IFN-  expression (Table I). To our
Table II. Impaired development of alloantigen-reactive T reg cells in the absence of IFN- 
Adoptive transfer
CD25 
CD45RBhigh Wild type IFN-  knockout
Evidence of necrosis
between days 7 and 11
( 50% of graft) Graft survival time Graft survival at 100 d
d
     7/7 4   17, 21, 2   22 0/7
     3/9 17, 31, 46, 6   100 6/9
     9/9 2   17, 2   22, 2   31, 46, 94, 100 1/9a
aP   0.01.
Figure 7. IFN-  mRNA expression and protein production by 
alloantigen-reactive regulatory T cells after in vitro stimulation. 
CD25 CD4  and CD25 CD4  T cells from 177/B10DST-pretreated and 
naive CBA mice were purified from the spleen by flow cytometry. 2   105 
purified T cells were stimulated with 5   105 B10 splenocytes in vitro. At 
different time points, cells and supernatants were harvested from the 
cultures for analysis of IFN-  transcription and protein production by real 
time RT-PCR and ELISA, respectively.INTERFERON-  PRODUCTION BY REGULATORY T CELLS | Sawitzki et al. 1932
knowledge, this is the first report that analyzes cytokine ex-
pression by alloantigen-reactive T reg cells after antigen ex-
posure in vivo.
The fivefold increase in IFN-  mRNA expression in
CD25 CD4  T cells after restimulation by donor alloanti-
gen was detectable despite only a small fraction of the
CD25 CD4  T cells that were present in the spleen being
donor alloantigen specific, suggesting that this is an underes-
timate of the increase in the alloantigen-reactive cells them-
selves. IFN-  mRNA expression by CD25 CD4  T cells
did not change after rechallenge with alloantigen in vivo
(Fig. 2). These data differ from previous results—where in
contrast to naive T cells—CD25 CD4  T reg cells pro-
duced little or no IFN-  after stimulation in vitro (6–8).
These contradictory observations may be due to a kinetic
difference in IFN-  expression between CD25 CD4  T reg
cells and naive T cells. Although up-regulation of IFN- 
mRNA production by CD25 CD4  alloantigen-reactive T
reg cells was very rapid, transcription was not sustained (Fig.
2). Therefore, it is possible that up-regulation of IFN- 
mRNA expression by naive CD25 CD4  T cells after al-
loantigen stimulation in vivo occurs in a delayed fashion
(i.e., later than the day 3 time point studied here), but is long
lasting. Stimulation of CD25 CD4  T cells from 177/
B10DST-pretreated CBA mice with B10 splenocytes in
vitro also resulted in a rapid increase in IFN-  transcription
with subsequent protein production (Fig. 7).
CD25 CD4  T cells from naive CBA mice had a two-
fold higher expression of IFN-  mRNA compared with
CD25 CD4  T cells (Fig. 2) as reported previously (15), and
up to 50-fold higher levels of IL-10 mRNA compared with
CD25 CD4  T cells (Fig. 2). This latter observation is in ac-
cordance with previous findings from our own and several
other laboratories which demonstrated that CD25 CD4  T
reg cells require an environment with intact IL-10 produc-
tion and signaling to regulate the activity of effector T cells in
vivo (1–3). When challenged with alloantigen in vivo,
CD25 CD4  T reg cells did up-regulate IL-10 mRNA ex-
pression (Fig. 2); however, a twofold increase in IL-10
mRNA expression also was detected when the mice were
challenged with third-party antigen (Fig. 3), although CD25 
CD4  T cells from pretreated mice cannot inhibit rejection
of third-party skin grafts at the same cell number (3).
CD25 CD4  and CD25 CD4  T cells from naive mice
had a similar basal level of IL-2 mRNA expression, and both
populations from pretreated mice responded by increasing
IL-2 transcription after restimulation with donor alloantigen
in vivo (Fig. 2). Thus, in contrast to in vitro findings (6–8),
alloantigen-reactive T reg cells and activated naive T cells
up-regulate IL-2 mRNA expression after antigen stimula-
Figure 8. CD25 CD4  T cells from YTS177/B10DST-pretreated 
mice can inhibit cytokine expression by CD45RBhighCD4  T cells in 
vitro. CD45RBhighCD4  T cells from naive CBA mice were cultured alone or 
cocultured with CD25 CD4  T cells from YTS177/B10DST-pretreated CBA 
mice in the presence of neutralizing anti–IFN-  antibody or an isotype 
control. 5   105 B10 splenocytes were added to the cultures. After 96 h, 
cells and supernatants were harvested for real time RT-PCR and ELISA 
analysis of IL-2 and IFN-  transcription and protein production.JEM VOL. 201, June 20, 2005 1933
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tion in vivo. Whether this is limited to mRNA expression or
also applies to IL-2 protein synthesis and secretion needs to
be investigated further.
Early expression of IFN-  by alloantigen-reactive T reg
cells was required for regulatory activity in vivo (Table I).
Neutralization of IFN-  signaling resulted in attenuated con-
trol of skin allograft rejection by CD25 CD4  T cells from
pretreated mice in vivo, as evidenced by the onset of graft ne-
crosis in all mice (Table I). Furthermore, CD25 CD4  T
cells from IFN- –deficient mice were unable to control skin
allograft rejection. This is not without precedent because reg-
ulatory and antiinflammatory properties of IFN-  were de-
scribed previously (16, 17). Endogenous IFN-  has been
shown to act as a protective factor against the onset of exper-
imental autoimmune encephalomyelitis (EAE; references 18–
20) and to exert global suppressive effects on T cell trafficking
in an asthma model (21). Moreover, transplantation tolerance
cannot be induced in IFN-  knockout mice (10, 22, 23).
IFN-  also is required for T cell depletion and prevention of
graft versus host disease by agonistic anti-CD28 antibodies
(24). Recently Nishibori et al. reported on an impaired
development of CD25 CD4  T reg cells in signal trans-
ducer and activator of transcription (STAT)-1–deficient mice
which was associated with an increased susceptibility to au-
toimmune disease (25). The STAT1 transcription factor plays
an important role in IFN- –induced signaling, and indicates
that IFN- –induced STAT1 activation is important for the
development and function of CD25 CD4  T reg cells.
Early administration of IL-12 between days 0 and 5 can
suppress EAE through induction of IFN-  whereas late ad-
ministration between days 9 and 14 had no effect (26). In
this study, the IL-12 treatment induced an early induction of
IFN-  (day 7) in antigen-specific T cells; however, the late
IFN-  and TNF-  response (day 21) was decreased. This
was associated with a diminished mononuclear cell infiltra-
tion and demyelination. The beneficial effect of early IL-12
administration was clearly dependent on IFN-  production
because IL-12–treated IFN- –deficient mice developed se-
vere EAE. Similar findings were made by Tarrant et al. in a
model of experimental autoimmune uveitis (16).
Although IFN-  may elicit inflammatory Th1-driven
immune responses in some circumstances, it may exert an
immunosuppressive effect in others. This functional dichot-
omy probably is dependent on the IFN-  concentration, the
microenvironment, and the timing of IFN-  production.
Further evidence from our in vitro studies supports the role
of IFN-  for the regulatory capacity of CD25 CD4  T
cells. We have demonstrated that CD25 CD4  T cells from
177/B10DST-pretreated CBA mice also are able to inhibit
activation of CD45RBhighCD4  T cells in vitro; this could
be restored by the addition of a neutralizing anti–IFN-  an-
tibody to the coculture (Fig. 8).
The main antiinflammatory properties of IFN-  are in-
duction of apoptosis and inhibition of proliferation (14, 23,
27). By expressing both types of IFN-  receptors (IFNR1
and IFNR2), only naive and Th2 cells are sensitive to IFN- 
(28, 29). T cells lose expression of the signaling chain IFNR2
as they develop into Th1 cells, and therefore, become resis-
tant to IFN-  signaling. Hence, an early transient expression
of IFN-  by alloantigen-reactive T reg cells could prevent
the initiation of graft rejection by inhibiting activation and
proliferation of naive alloreactive T cells or by controlling al-
loreactive effector mechanisms. Evidence in support of the
latter effect was reported recently by Lin et al. who showed
that CD4  T reg cells did not prevent proliferation or accu-
mulation of alloreactive CD8  T cells, but rather, inhibited
their cytotoxic effector functions by unknown mechanisms
(30). Corroborate findings have been made by two other
groups (31, 32). In contrast, Lee et al. observed an inhibition
of effector cell proliferation by CD25 CD4  T reg cells in
vivo (33). Continued signaling via IFNR2 in CD4  T cells
was shown to lead to impaired Th1-dependent immunity in
vivo. CD4  T cells from IFNR2 transgenic mice still could
proliferate upon stimulation in vitro and in vivo, but failed
to elicit delayed-type hypersensitivity responses and initiate
clearance of Leishmania major (28). Thus, IFN-  production
by alloantigen-reactive T reg cells may influence the ability of
effector T cells to initiate graft rejection.
IFN-  production by T reg cells also may influence the
expansion of GR1  macrophages that can suppress the pro-
liferation of naive T cells by a nitric oxide–dependent mech-
anism (34). In this study, IFN-  neutralization was accom-
panied by a massive reduction in iNOS mRNA expression
within skin grafts in which immunoregulation was abrogated
(Fig. 6). Furthermore, CD25 CD4  T reg cells were shown
to modulate tryptophan catabolism of dendritic cells, and
thereby, prime them for tolerance induction (35). In resting
CD25 CD4  T cells, this effect was mediated via surface
expression of CTLA4 which subsequently led to an increase
in IFN-  and indoleamine-2,3-dioxygenase (IDO) pro-
duction in the cocultured dendritic cells. In contrast, anti-
CD3 and LPS stimulation induced IFN-  production by
CD25 CD4  T cells which led to even greater IDO pro-
duction and tolerogenic potential of the cocultured dendritic
cells. Similar to iNOS mRNA expression, IDO expression
also was reduced in skin grafts of recipients of a neutralizing
antibody against IFN-  (unpublished data).
Thus, the protective role of early IFN-  expression by
alloantigen-reactive T reg cells in this model of skin allograft
rejection may arise from a direct effect of IFN-  on naive T
cells or indirectly as a result of nitric oxide production by ac-
tivated residual macrophages or by an increase in IDO pro-
duction of dendritic cells.
In this study, we associate IFN-  with the action of
T reg cells, and thereby, identify a possible mechanism
whereby T reg cells may influence directly the proliferation
and effector function of alloreactive T cells in vivo. Further-
more, our findings may explain why IFN-  acts as a protec-
tive factor in certain autoimmune models and is essential in
some transplant models of long-term graft acceptance.INTERFERON-  PRODUCTION BY REGULATORY T CELLS | Sawitzki et al. 1934
MATERIALS AND METHODS
Mice. CBA.Ca (CBA, H2k), C57BL/10 (B10, H2b), C57BL/6 (BL6,
H2b), BALB/c (H2d), and CBA Rag1 /  (H2k) were bred in the SPF facil-
ity, Biomedical Services, John Radcliffe Hospital. IFN- ( / ) C57BL/6
were provided by U. Klemm, Max Plank Institute of Infection Biology
(Berlin, Germany). Sex-matched mice aged 6–12 weeks were used in all ex-
periments. All mice were bred and used in accordance with the Animals
(Scientific Procedure) Act 1986 of the United Kingdom.
Reagents and monoclonal antibodies. Hybridomas YTS 169.4.2 (anti-
CD8) and YTS 177.9 (anti-CD4) were provided by Professor H. Wald-
mann (Sir William Dunn School of Pathology, Oxford, England, United
Kingdom). The neutralizing anti–IFN-  antibody (clone: AN 18.17.24)
was provided by U. Syrbe (German Rheumatology Research Centre, Ber-
lin, Germany). TIB120 (anti-MHC II) was obtained from American Type
Culture Collection. RM4-5 (anti-CD4)-cychrome, 16A (anti-CD45RB)-
PE, 7D4 (anti-CD25)-biotin, and streptavidin-PE were purchased from
BD. The following mAbs were used for in vivo experiments: anti–mouse
IFN-  (clone AN 18.17.24, 200  g at time of adoptive transfer) and GL113
(rat IgG1, 200  g at time of adoptive transfer), an isotype control mAb re-
active with  -galactosidase (36).
Cell preparation. Single-cell suspensions from spleen of naive or pre-
treated CBA mice were prepared as described previously (3). CD25 CD4 ,
CD25 CD4 , or CD45RBhighCD4  T cells were obtained by flow cytom-
etry using a FACSVantage or FACSAria (Becton Dickinson). On reanalysis,
all populations were  95% pure.
Cell culture. Culture medium was composed of RPMI 1640 supple-
mented with 10% FCS (both P.A.A. Laboratories GmBH), 2 mM L-gluta-
mine, 0.5 mM 2-mercaptoethanol (Sigma-Aldrich), and 100 units/ml each
penicillin, streptomycin, and kanamycin. All cultures were set in U-shaped
96-well plates (Corning Costar). CD45RBhighCD4  T cells from naive CBA
mice and CD25 CD4 , CD25 CD4  T cells from naive or pretreated
CBA mice were cultured at 2   105 cells per well together with 5   105 ir-
radiated (3600 rad) allogeneic total splenocytes from B10 mice. For cocul-
ture experiments, 2   105 CD45RBhighCD4  T cells from naive CBA mice
were cultured with 105 (2:1) or 2   105 (1:1) CD25 CD4  T cells from
pretreated CBA mice and 5   105 irradiated B10 splenocytes in the presence
of 20  g/ml neutralizing anti–mouse IFN-  antibody or control isotype.
Cytokine mRNA expression. Sorted cells or skin grafts were analyzed
for the expression of mRNA encoding IL-2, IFN- , and IL-10 by quantita-
tive real time RT-PCR (TaqMan; PE Biosystems). RNA isolation and
cDNA synthesis were performed as described previously. The cDNA was
analyzed for cytokine gene expression by TaqMan PCR as described (37). If
not otherwise indicated, CD3 was used as a housekeeping gene and mRNA
concentrations were compared with the sample content of CD3. The se-
quences of the oligonucleotides used are as follows: CD3 sense 5 -ATT-
GCGGGACAGGATGGAG-3 ; CD3 antisense 5 -CTTGGAGATGGCT-
GTACTGGTCA-3 ;  CD3 probe 5 -TCGCCAGTCAAGAGCTTCA-
GACAAGCA-3 ; IL-2 sense 5 -CCCAGGATGCTCACCTTCAA-3 ; IL-2
antisense 5 -CATGCCGCAGAGGTCCAA-3 ;  IL-2 probe 5 -CAAT-
TCTGTGGCCTGCTTGGGCAA-3 ; IFN-  sense 5 -AGCAACAGCA-
AGGCGAAAAA-3 ;  IFN-  antisense 5 -AGCTCATTGAATGCTTG-
GCG-3 ;  IFN-  probe 5 -ATTGCCAAGTTTGAGGTCAACAACCC-
ACA-3 ; IL-10 sense 5 -GAAGACCCTCAGGATGCGG-3 ; IL-10 anti-
sense 5 -CCTGCTCCACTGCCTTGCT-3 ; IL-10 probe 5 -CGCTGT-
CATCGATTTCTCCCCTGTGA-3 ;  TGF-  sense 5 -GGCTACCAT-
GCCAACTTCTGTCT-3 ;  TGF-  antisense 5 -CCGGGTTGTGTT-
GGTTGTAGA-3 ;  TGF-  probe 5 -CACACAGTACAGCAAGGTC-
CTTGCCCT-3 ; CTLA4 sense 5 -AACTCATGTACCCACCGCCA-3 ;
CTLA4 antisense 5 -TCCAAAGGAGGAAGTCAGAATCC-3 ;  CTLA4
probe 5 -TTATGTCATTGATCCAGAACCATGCCCG-3 ;  HPRT
sense 5 -ATCATTATGCCGAGGATTTGGAA-3 ; HPRT antisense 5 -
TTGAGCACACAGAGGGCA-3 ; HPRT probe 5 -TGGACAGGACT-
GAAAGACTTGCTCGAGATG-3 ; iNOS sense 5 -CTTTGACGCTC-
GGAACTGTAGC-3 ;  iNOS antisense 5 -TGAAGTCATGTTTGC-
CGTCACT-3 ; and iNOS probe 5 -GCAACATCAGGTCGGCCAT-
TACTGTGTT-3 . Sense and antisense oligonucleotides were purchased
from MWG. The probes were labeled with the reporter FAM (6-carboxy-
fluorescein) at the 5  end and with the quencher TAMRA (6-carboxy-tet-
ramethyl-rhodamine) at the 3  end (both from Oswel).
ELISA. Cell culture supernatants were analyzed for IL-2 and IFN-  secre-
tion at the time points indicated using commercially available antibody pairs
and standards (BD Biosciences).
Adoptive transfer and skin transplantation. T cell–deficient [Rag( / )]
CBA mice were reconstituted i.v. with syngeneic fractionated T cells. The
day after reconstitution, all mice received a B10 skin graft as described pre-
viously (3). Graft rejection was defined as complete destruction of the skin
grafts.
Statistical analysis. Data were analyzed using the statistical software SPSS
(SPSS GmbHSoftware) and are reported as mean   SD. Data for cytokine
expression were analyzed using one-way ANOVA with Bonferroni correc-
tion. Graft survival data were analyzed using Kaplan Meier Log Rank test.
Differences were considered significant when P   0.05.
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